News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,551 Results
Type
Article (8055)
Company Profile (140)
Press Release (476355)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166792)
Career Advice (313)
Deals (25742)
Drug Delivery (7)
Drug Development (52900)
Employer Resources (14)
FDA (9763)
Job Trends (8584)
News (238253)
Policy (17908)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (487)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33169)
ALS (104)
Alzheimer's disease (974)
Antibody-drug conjugate (ADC) (262)
Approvals (10373)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (206)
Automation (28)
Bankruptcy (262)
Best Places to Work (6971)
BIO (36)
BIOSECURE Act (1)
Biosimilars (108)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (507)
Cancer (3629)
Cardiovascular disease (227)
Career advice (252)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47870)
Collaboration (1239)
Commercialization (3)
Compensation (1452)
Complete response letters (34)
COVID-19 (756)
CRISPR (64)
C-suite (737)
Cystic fibrosis (85)
Data (5630)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (341)
Diagnostics (4179)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73701)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87601)
Executive appointments (698)
FDA (12373)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (912)
Gene editing (126)
Generative AI (9)
Gene therapy (315)
GLP-1 (289)
Government (950)
Grass and pollen (2)
Guidances (281)
Healthcare (9331)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (99)
Immuno-oncology (56)
Indications (156)
Infectious disease (944)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (44)
IPO (12390)
IRA (2)
Job creations (1969)
Job search strategy (241)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (505)
Lymphoma (249)
Machine learning (27)
Management (3)
Manufacturing (528)
Marketing (8)
MASH (118)
Medical device (8653)
Medtech (8793)
Mergers & acquisitions (14381)
Metabolic disorders (704)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1819)
NextGen: Class of 2026 (3161)
Non-profit (846)
Now hiring (1)
Obesity (223)
Opinion (11)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (502)
Peanut (31)
People (41241)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15465)
Phase 2 (21380)
Phase 3 (14406)
Pipeline (7253)
Policy (18)
Postmarket research (1573)
Preclinical (6537)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (569)
Real estate (3022)
Recruiting (6)
Regulatory (14807)
Reports (20)
Research institute (582)
Resumes & cover letters (49)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (153)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2025)
Stomach cancer (3)
Supply chain (50)
Vaccines (318)
Venture capital (18)
Weight loss (73)
Women's health (78)
Date
Today (27)
Last 7 days (449)
Last 30 days (1605)
Last 365 days (19063)
2026 (12109)
2025 (19259)
2024 (22987)
2023 (26545)
2022 (34604)
2021 (37175)
2020 (33482)
2019 (23281)
2018 (17471)
2017 (18771)
2016 (17917)
2015 (24270)
2014 (21689)
2013 (18136)
2012 (20222)
2011 (20442)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17895)
Australia (2097)
California (11918)
Canada (3128)
China (517)
Colorado (482)
Connecticut (408)
Delaware (207)
Europe (24631)
Florida (1782)
Georgia (376)
Hawaii (3)
Idaho (46)
Illinois (695)
India (48)
Indiana (314)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (26)
Maine (26)
Maryland (1194)
Massachusetts (7831)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2622)
New Mexico (12)
New York (2811)
North Carolina (1267)
North Dakota (4)
Northern California (5969)
Ohio (276)
Oklahoma (14)
Oregon (16)
Pennsylvania (2245)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4946)
Tennessee (119)
Texas (1927)
United States (38706)
Utah (358)
Vermont (1)
Virginia (152)
Washington D.C. (38)
Washington State (923)
West Virginia (1)
Wisconsin (73)
484,551 Results for "myokardia inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Series A
MyoKardia Alumni Launch Kardigan with $300M to Tackle Heart Disease
After the successful development of mavacamten and the sale of MyoKardia to BMS in 2020, former executives of the biotech are back together with a mission to make cardiovascular disease curable and preventable.
January 10, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Business
MyoKardia Reports Third Quarter 2020 Financial ResultsAcquisition of MyoKardia by Bristol-Myers Squibb Expected to Close During 4th Quarter of 2020
MyoKardia, Inc. reported financial results for the third quarter ended September 30, 2020.
November 5, 2020
·
10 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
Business
MyoKardia Reports Second Quarter 2020 Financial Results
MyoKardia, Inc. (Nasdaq: MYOK), today reported financial results for the second quarter ended June 30, 2020.
August 4, 2020
·
12 min read
Business
MyoKardia Announces Awardees of the Second Annual MyoSeeds™ Research Grants Program
MyoKardia, Inc. (Nasdaq: MYOK) today announced three awardees of the 2020 MyoSeeds™ Research Grant Program, who have been selected to receive $250,000 each in support of original, independent research in the biology and underlying mechanisms of cardiomyopathies. The MyoSeeds Program was founded to help advance MyoKardia’s mission to promote understanding and treatment of the underlying drivers of serious cardiovascular diseases. More than
November 4, 2020
·
4 min read
Business
MyoKardia Reports First Quarter 2020 Financial Results
MyoKardia, Inc., reported financial results for the first quarter ended March 31, 2020.
May 6, 2020
·
8 min read
Deals
Bristol Myers Squibb Completes Acquisition of MyoKardia, Strengthening Company’s Leading Cardiovascular Franchise
Bristol Myers Squibb (NYSE:BMY) announced today that it has successfully completed its acquisition of MyoKardia, Inc. in an all cash transaction for approximately $13.1 billion. With the completion of the acquisition, MyoKardia shares have ceased trading on the NASDAQ Global Select Market and MyoKardia is now a wholly-owned subsidiary of Bristol Myers Squibb. “We are excited to welcome MyoKardia colleagues to Bristol Mye
November 17, 2020
·
7 min read
Press Releases
Biogen Completes Acquisition of RayThera Inc.
August 7, 2026
·
7 min read
Business
MyoKardia Announces Appointment of Denelle J. Waynick as General Counsel and Corporate Secretary
MyoKardia, Inc. (Nasdaq: MYOK) today announced the appointment of Denelle Waynick as General Counsel and Corporate Secretary. Ms. Waynick joins MyoKardia from UCB, Inc., bringing more than 25 years of domestic and international legal and business expertise in the healthcare and life-science industry. Cynthia Ladd, who has been leading MyoKardia’s legal function as General Counsel since January 2018, will be retiring this year. “Denelle is
July 6, 2020
·
3 min read
1 of 48,456
Next
